292 related articles for article (PubMed ID: 38507271)
1. New insights on testicular cancer prevalence with novel diagnostic biomarkers and therapeutic approaches.
Sadek KM; AbdEllatief HY; Mahmoud SFE; Alexiou A; Papadakis M; Al-Hajeili M; Saad HM; Batiha GE
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2052. PubMed ID: 38507271
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Kawai T; Tanaka Y;
Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
[TBL] [Abstract][Full Text] [Related]
3. [Testicular cancer. Standard management leads to recovery in 90 to 95 percent of the cases].
Berger N; Droz JP
Rev Prat; 2007 Feb; 57(4):361-3. PubMed ID: 17455737
[No Abstract] [Full Text] [Related]
4. [Management of testicular cancer].
Schneevoigt B; Stief CG; Karl A
MMW Fortschr Med; 2013 Dec; 155(21-22):40-2. PubMed ID: 24724271
[No Abstract] [Full Text] [Related]
5. [Testicular tumors--a current review].
Buse S; Lurati G; Schmid HP
Praxis (Bern 1994); 2003 Nov; 92(47):1989-97. PubMed ID: 14669500
[TBL] [Abstract][Full Text] [Related]
6. Current concepts in clinical therapeutics: testicular cancer.
Bergmann KA
Clin Pharm; 1987 Sep; 6(9):693-706. PubMed ID: 2445518
[TBL] [Abstract][Full Text] [Related]
7. miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update.
De Martino M; Chieffi P; Esposito F
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573132
[TBL] [Abstract][Full Text] [Related]
8. A scoping review on the "burned out" or "burnt out" testicular cancer: When a rare phenomenon deserves more attention.
Iannantuono GM; Strigari L; Roselli M; Torino F
Crit Rev Oncol Hematol; 2021 Sep; 165():103452. PubMed ID: 34384861
[TBL] [Abstract][Full Text] [Related]
9. Bilateral germ-cell testicular cancer - long-term experience.
Ondruš D; Ondrušová M; Št'astná V
Klin Onkol; 2013; 26(6):421-4. PubMed ID: 24320591
[TBL] [Abstract][Full Text] [Related]
10. [Recommendations Onco-Urology 2010: Germ cell testicular tumors.].
Durand X; Rigaud J; Avances C; Camparo P; Culine S; Iborra F; Mottet N; Sèbe P; Soulié M;
Prog Urol; 2010 Nov; 20 Suppl 4():S297-309. PubMed ID: 21129648
[No Abstract] [Full Text] [Related]
11. Mixed or non-seminomatous germ-cell tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Huddart R; Kataja V;
Ann Oncol; 2008 May; 19 Suppl 2():ii52-4. PubMed ID: 18456768
[No Abstract] [Full Text] [Related]
12. Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.
Bu L; Yang Q; McMahon L; Xiao GQ; Li F
Exp Mol Pathol; 2019 Oct; 110():104293. PubMed ID: 31381875
[TBL] [Abstract][Full Text] [Related]
13. Testicular carcinoma.
O'Callaghan A; Mead GM
Postgrad Med J; 1997 Aug; 73(862):481-6. PubMed ID: 9307739
[TBL] [Abstract][Full Text] [Related]
14. Primary mediastinal germ cell tumours with high prevalence of somatic malignancy: An experience from a single tertiary care oncology centre.
Beg A; Kumar R; Sahay A; Janu A; Joshi A; Noronha V; Prabhash K; Karimundackal G; Jiwnani S; Agarwal JP; Pramesh CS
Ann Diagn Pathol; 2021 Aug; 53():151763. PubMed ID: 34111707
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond.
Egan J; Salari K
Urol Clin North Am; 2023 Feb; 50(1):133-143. PubMed ID: 36424077
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Care and Survival Outcomes for Malignant Sex Cord Stromal Testicular Cancer: Results from the National Cancer Data Base.
Banerji JS; Odem-Davis K; Wolff EM; Nichols CR; Porter CR
J Urol; 2016 Oct; 196(4):1117-22. PubMed ID: 27036305
[TBL] [Abstract][Full Text] [Related]
17. Second malignancies in long-term testicular cancer survivors.
Ondrus D; Ondrusova M; Friedova L
Int Urol Nephrol; 2014 Apr; 46(4):749-56. PubMed ID: 24096370
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the biology of germ cell tumors: implications for the diagnosis and treatment.
Chieffi P; Chieffi S; Franco R; Sinisi AA
J Endocrinol Invest; 2012 Dec; 35(11):1015-20. PubMed ID: 23143673
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, staging, and risk factors: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.
Albers P; Algaba F; Cohn-Cedermark G; DeSantis M; Kliesch S; Moul JW
Urology; 2011 Oct; 78(4 Suppl):S427-34. PubMed ID: 21986222
[No Abstract] [Full Text] [Related]
20. An update on diagnostic tissue-based biomarkers in testicular tumors.
Siegmund SE; Mehra R; Acosta AM
Hum Pathol; 2023 Mar; 133():32-55. PubMed ID: 35932825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
